StimCell Enegetics IncOTC Pink - Current Information:CMXCD
- LAST PRICE0.0015
- TODAY'S CHANGE (%)-0.4965 (-99.6988%)
- Bid / Lots0.0500/ 100
- Ask / Lots0.4840/ 25
- Open / Previous Close0.0015 / 0.4980
- Day Range
- 52 Week Range
- Volume209
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CMXCD |
|---|---|---|
| 09:32 ET | 200 | 0.0015 |
Nov 4, 2024
StimCell Energetics Inc. (Formerly "Cell MedX Corp.") Announces Major Corporate Updates and Rebranding, from 1:38PM ET on Monday Nov 04, 2024 by Dow Jones
1:38PM ET on Monday Nov 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
StimCell Enegetics Inc | 9.9M | -1.4x | --- |
NKGen Biotech Inc | 9.7M | -0.1x | --- |
Conduit Pharmaceuticals Inc | 9.7M | -1.4x | --- |
Vincerx Pharma Inc | 9.6M | -0.2x | --- |
CERo Therapeutics Holdings Inc | 10.4M | -0.2x | --- |
Mustang Bio Inc | 9.2M | -0.1x | --- |
Company Information
StimCell Enegetics Inc., formerly Cell MedX Corp., is a development stage electroceutical medical device company. The Company’s products include eBalance, and Bio Feedback. The eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms. The biofeedback mechanism is where eBalance offering users and health professionals alike a real-time snapshot of cellular vitality. Its Microcurrent therapy uses molecular bioelectricity in cell-to-cell signaling. Microcurrent is a clinically tested therapy treatment used to treat a range of conditions. There is compelling research in diabetes care, wound therapy, migraine treatment, chronic obstructive pulmonary disease (COPD), and anti-ageing.
Contact Information
- Headquarters
- 123 W. Nye Ln, Suite 446CARSON CITY, NV, United States 89706
- Phone
- 310-508-9398
- Fax
- 775-884-9383
Executives
- Chief Executive Officer, Director
- David Jeffs
- Chief Financial Officer, Treasurer, Corporate Secretary, Director
- Yanika Silina
- Director
- Amir Vahabzadeh
- Director
- Dwayne Yaretz
- Independent Director
- George Adams
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 31.0M |
StimCell Enegetics Inc does not pay a dividend. | |
Beta | --- |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
